Markets
Degenerate
@wsb
Bought SENS
Calls
down -16.67%
At 0.45, Now 0.38
Contract:
1.5 Strike Call for
Jan 16, 26
I'm bullish on SENS because the FDA-approved 365-day CGM is set to disrupt the market, especially as earnings on March 3 might raise revenue guidance ...
Read
More
Thesis
I'm bullish on SENS because the FDA-approved 365-day CGM is set to disrupt the market, especially as earnings on March 3 might raise revenue guidance for 2025. This could lead to significant price movement, and my purchase of calls reflects my confidence in this growth.
Go back
Tendies
@tendies
Bought SENS
Shares
0.0%
At 1.1, Exited 1.1
I'm really bullish on SENS because of its potential in the CGM market and strong partnerships that could drive significant market share. With the stoc...
Read
More
Thesis
I'm really bullish on SENS because of its potential in the CGM market and strong partnerships that could drive significant market share. With the stock priced low and a high short interest, I see a great risk/reward opportunity for a swing trade as positive news might trigger a short squeeze.
Go back
Stonks
@stocks
Bought SENS
Shares
up 22.95%
At 0.89, Exited 1.1
I believe SENS is positioned well with their new glucose monitor that only needs to be replaced once a year, following FDA approval. The growth in pat...
Read
More
Thesis
I believe SENS is positioned well with their new glucose monitor that only needs to be replaced once a year, following FDA approval. The growth in patient accounts is promising, and with the stock currently around .90, I see a good opportunity for a swing play as they work towards profitability.
Go back
Tendies
@tendies
Bought SENS
Shares
up 42.32%
At 0.61, Exited 0.88
With the positive earnings report and significant advancements in their 365-day CGM device, I feel bullish about SENS. The cancellation of the reverse...
Read
More
Thesis
With the positive earnings report and significant advancements in their 365-day CGM device, I feel bullish about SENS. The cancellation of the reverse stock split indicates confidence in the company's future, making me believe this stock could see a nice rise in value soon.
Go back
Tendies
@tendies
Bought SENS
Shares
up 56.58%
At 0.48, Exited 0.75
I'm feeling really bullish on SENS because analysts are projecting a substantial upside to $2.50 from its current price of $0.50. The recent FDA appro...
Read
More
Thesis
I'm feeling really bullish on SENS because analysts are projecting a substantial upside to $2.50 from its current price of $0.50. The recent FDA approval for their long-lasting glucose monitor is a game-changer, and I believe the stock will attract a lot of attention this week.
Go back
